Mechanism of Action and Pharmacokinetics
The drug's action is based on the inhibition of sodium ion ($Na^+$) reabsorption in the renal tubules. Chemically, Furosemidum is classified as a weak acid (pKa 3.9, meaning it has the ability to donate a proton).
In the kidneys, the drug undergoes active tubular secretion in the proximal tubules (tubuli proximales). This process occurs against a concentration gradient and requires energy. Unlike glomerular filtration, secretion effectively removes substances that are tightly bound to plasma proteins. The physiological basis of this phenomenon is as follows: as a substance is secreted from the blood into the tubular lumen, the plasma volume does not decrease $\rightarrow$ only the concentration of the free substance drops $\rightarrow$ the equilibrium is disturbed $\rightarrow$ protein-bound drug molecules dissociate and become available for elimination.
Transport is mediated by specialized systems for organic acids (anions). This process involves SLC transporter families (located on both the basolateral and apical membranes of epithelial cells) and ATP-dependent ABC transporters (on the apical membrane). Due to the limited capacity of carrier proteins, furosemide can compete with other organic acids (e.g., penicillins or salicylates), slowing down their excretion.
Pharmacological Effects
The primary pharmacokinetic feature of the drug is its short latency period, ensuring a rapid onset of diuretic action.
In addition to its powerful diuretic effect, intravenous administration of furosemide produces a direct venodilating effect. Venodilation leads to a rapid reduction in cardiac preload and a drop in blood pressure (BP). It is important to note that this rapid hypotensive effect is driven specifically by vascular effects rather than fluid loss through urination.
Clinical Application
Due to its rapid onset of action, the drug is a first-line treatment for medical emergencies, primarily for managing cerebral edema and pulmonary edema.
Furosemide is also used in the chronic management of hypertension.
In toxicology, the drug is used in forced diuresis protocols to eliminate absorbed poisons (detoxification). This method involves the intravenous administration of a large volume of fluid (1–2 liters of 0.9% NaCl solution) followed by a potent diuretic, leading to the rapid washout of toxins from the bloodstream.
Adverse Effects and Safety Profile
The potent diuretic action is associated with several serious adverse reactions:
- Electrolyte disturbances: Intensive ion excretion leads to hypokalemia (low blood potassium levels).
- Metabolic abnormalities: The drug promotes hyperuricemia (elevated uric acid levels) and hyperlipidemia.
- Specific toxicity: Furosemide exhibits ototoxicity, meaning it can exert a negative impact on hearing.
Formulations and Dosing Guidelines
The drug is available in two main formulations:
- Tablets (40 mg). Administered orally before meals. The initial dose ranges from 20 to 40 mg. If necessary, the dose may be increased to 80–160 mg/day (divided into 2–3 doses).
- Solution in ampoules (1% — 2 mL). Administered intramuscularly or intravenously (slow bolus) at 20–60 mg 1–2 times daily.